Drug intelligence / Profile preview

miR-378a-5p mimic

Development stage
Preclinical
Lead developer
IRCCS Regina Elena National Cancer Institute
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

miR-378a-5p mimic is a synthetic double-stranded RNA oligonucleotide designed to simulate the biological activity of the endogenous microRNA miR-378a-5p. Research presented at AACR 2019 indicates that miR-378a-5p acts as a positive regulator of melanoma progression, enhancing tumor cell invasion and vasculogenic mimicry. The mimic functions by binding to the 3' untranslated regions (UTRs) of specific target mRNAs, including SUFU, STAMBP, and KLF9, leading to their degradation or translational inhibition. This modulation results in the upregulation of pro-angiogenic factors such as VEGF and uPAR, facilitating de novo vasculogenic structure formation and endothelial cell capillary-like structure formation. While currently utilized primarily as a research tool to elucidate the molecular mechanisms of melanoma metastasis and angiogenesis, miR-378a-5p and its downstream pathways represent potential targets for therapeutic intervention.

Other names
microRNA-378a-5p mimicmicroRNA378a-5p mimicmicroRNA 378a-5p mimichsa-miR-378a-5p mimichsa-miR378a-5p mimichsa-miR 378a-5p mimic
02

Targets

IRF1 (Interferon regulatory factor 1)STAMBPCAMKK2 (Calcium/calmodulin-dependent protein kinase kinase 2)HOX (HOX transcription factor family)PLAUR (Urokinase plasminogen activator receptor)SUFU (Suppressor of fused homolog)VEGFA (Vascular endothelial growth factor A)KLF9 (Krüppel-like factor 9)Cyclin-dependent kinase 1 (CDK1) mRNA

Beyond the preview

Go deeper on miR-378a-5p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-378a-5p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call